KHERA; Brij
Patent Applications and Registrations
Patent applications and USPTO patent grants for KHERA; Brij.The latest application filed is for "pharmaceutical compositions of sitagliptin".
- KHERA; Brij - Pennington NJ
- Khera; Brij - Gujarat IN
- Khera; Brij - Ahmedabad IN
- Khera; Brij - North Pennington NJ US
- Khera; Brij - Princeton NJ
| Patent | Date |
|---|---|
| Pharmaceutical Compositions Of Sitagliptin App 20210137920 - KHERA; Brij ; et al. | 2021-05-13 |
| Pharmaceutical compositions of sitagliptin Grant 10,925,871 - Khera , et al. February 23, 2 | 2021-02-23 |
| Amorphous vortioxetine and salts thereof Grant 10,414,741 - Dwivedi , et al. Sept | 2019-09-17 |
| Processes for the preparation of lorcaserin Grant 9,714,225 - Dwivedi , et al. July 25, 2 | 2017-07-25 |
| Process for the preparation of apixaban Grant 9,603,846 - Khera , et al. March 28, 2 | 2017-03-28 |
| Pharmaceutical Compositions Of Sitagliptin App 20160367552 - KHERA; Brij ; et al. | 2016-12-22 |
| Processes For The Preparation Of Lorcaserin App 20160280658 - DWIVEDI,; Shriprakash Dhar ; et al. | 2016-09-29 |
| Pharmaceutical compositions of lurasidone Grant 9,433,620 - Khera , et al. September 6, 2 | 2016-09-06 |
| An Amorphous Vortioxetine And Salts Thereof App 20160214949 - DWIVEDI; Shri Prakash Dhar ; et al. | 2016-07-28 |
| Amorphous form of apremilast Grant 9,351,957 - Khera , et al. May 31, 2 | 2016-05-31 |
| Process For The Preparation Of Apixaban App 20160143894 - KHERA; Brij ; et al. | 2016-05-26 |
| Polymorphic Forms Of Lomitapide And Its Salts And Processes For Their Preparation App 20160083345 - DESAI; Sanjay Jagdish ; et al. | 2016-03-24 |
| Amorphous Form Of Canagliflozin And Process For Preparing Thereof App 20160083374 - DWIVEDI; Shriprakash Dhar ; et al. | 2016-03-24 |
| Stable Pharmaceutical Compositions Of Mesalamine App 20160045442 - Khera; Brij ; et al. | 2016-02-18 |
| Stable Pharmaceutical Package Comprising Azilsartan Medoxomil App 20160008328 - KHERA; BRIJ ; et al. | 2016-01-14 |
| Amorphous Form Of Dapagliflozin 1,2-propanediol App 20150307540 - DWIVEDI; Shri Prakash Dhar ; et al. | 2015-10-29 |
| Amorphous Form Of Apremilast App 20150283249 - KHERA; Brij ; et al. | 2015-10-08 |
| Method of preparation of pitavastatin and pharmaceutical acceptable salts thereof Grant 9,139,527 - Dwivedi , et al. September 22, 2 | 2015-09-22 |
| Pharmaceutical Compositions Of Mesalamine App 20150196518 - Khera; Brij ; et al. | 2015-07-16 |
| Method of Preparation of Pitavastatin and Pharmaceutical Acceptable Salts Thereof App 20150152061 - Dwivedi; Shriprakash Dhar ; et al. | 2015-06-04 |
| Pitavastatin calcium and process for its preparation Grant 9,034,901 - Dwivedi , et al. May 19, 2 | 2015-05-19 |
| Delayed Release Pharmaceutical Compositions of Salsalate App 20150037408 - Shantilal; Kothari Jay ; et al. | 2015-02-05 |
| Pharmaceutical Compositions Of Lurasidone App 20140348909 - Khera; Brij ; et al. | 2014-11-27 |
| Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof Grant 8,829,186 - Dwivedi , et al. September 9, 2 | 2014-09-09 |
| Pitavastatin Calcium And Process For Its Preparation App 20140148481 - Dwivedi; Shriprakash Dhar ; et al. | 2014-05-29 |
| Novel amorphous form of sertraline hydrochloride App 20040063792 - Khera, Brij ; et al. | 2004-04-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 